These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24974817)

  • 21. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
    Seddon JM; Francis PJ; George S; Schultz DW; Rosner B; Klein ML
    JAMA; 2007 Apr; 297(16):1793-800. PubMed ID: 17456821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CFH and ARMS2 Polymorphisms Interact with Zinc Supplements in Cognitive Impairment in the Women's Health Initiative Hormone Trial.
    Kustra R; Awh CC; Rojas-Fernandez C; Zanke B
    J Alzheimers Dis; 2018; 66(2):707-715. PubMed ID: 30320589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
    Merle BM; Richard F; Benlian P; Puche N; Delcourt C; Souied EH
    PLoS One; 2015; 10(7):e0130816. PubMed ID: 26132079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
    Wang JJ; Buitendijk GH; Rochtchina E; Lee KE; Klein BE; van Duijn CM; Flood VM; Meuer SM; Attia J; Myers C; Holliday EG; Tan AG; Smith WT; Iyengar SK; de Jong PT; Hofman A; Vingerling JR; Mitchell P; Klein R; Klaver CC
    Ophthalmology; 2014 Mar; 121(3):667-75. PubMed ID: 24290803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of geographic atrophy and genotype in age-related macular degeneration.
    Klein ML; Ferris FL; Francis PJ; Lindblad AS; Chew EY; Hamon SC; Ott J
    Ophthalmology; 2010 Aug; 117(8):1554-9, 1559.e1. PubMed ID: 20381870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
    Yu JJ; Agrón E; Clemons TE; Domalpally A; van Asten F; Keenan TD; Cukras C; Chew EY;
    Ophthalmology; 2019 Feb; 126(2):261-273. PubMed ID: 30142373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Myers CE; Meuer SM; Gangnon RE; Sivakumaran TA; Iyengar SK; Lee KE; Klein BE
    JAMA Ophthalmol; 2013 Mar; 131(3):383-92. PubMed ID: 23494043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
    Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
    Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M
    Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CFH and LOC387715/ARMS2 genotypes and antioxidants and zinc therapy for age-related macular degeneration.
    Lee AY; Brantley MA
    Pharmacogenomics; 2008 Oct; 9(10):1547-50. PubMed ID: 18855541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study.
    Myers CE; Klein BE; Gangnon R; Sivakumaran TA; Iyengar SK; Klein R
    Ophthalmology; 2014 Oct; 121(10):1949-55. PubMed ID: 24953792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
    JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study.
    Ryu E; Fridley BL; Tosakulwong N; Bailey KR; Edwards AO
    Mol Vis; 2010 Dec; 16():2811-21. PubMed ID: 21197116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.
    Abbas RO; Azzazy HM
    Ophthalmic Genet; 2013 Dec; 34(4):209-16. PubMed ID: 23362846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CFH (rs1410996), HTRA1 (rs112000638) and ARMS2 (rs10490923) gene polymorphisms are associated with AMD risk in Spanish patients.
    Cruz-González F; Cieza-Borrella C; López Valverde G; Lorenzo-Pérez R; Hernández-Galilea E; González-Sarmiento R
    Ophthalmic Genet; 2014 Jun; 35(2):68-73. PubMed ID: 23534868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.